South Korea’s pharmaceutical sector uses IoT RFID technology for drug management
[ad_1]
Propofol, whose chemical name is 2,6-diisopropylphenol, is a new type of rapid and short-acting intravenous anesthetic commonly used clinically for induction of anesthesia, maintenance of anesthesia, and sedation of critically ill patients in ICU. It has the advantages of fast onset of anesthesia induction, rapid recovery and perfect functional recovery, and low incidence of postoperative nausea and vomiting. However, this kind of anesthetic is strong, and excessive use can cause general paralysis, and in severe cases, it can cause fainting. Criminals use the drug’s medicinal properties to carry out criminal activities.
In South Korea, the pharmaceutical department and the Food and Drug Safety Agency have developed an RFID medical product management system using IoT RFID technology. The system is mainly for the management and restriction of narcotic drugs such as propofol, which are highly dependent. Set up electronic tags on the packaging of relevant drugs. The National Food and Drug Administration monitors the production and circulation of the drug at any time through RFID electronic tags, monitors the flow and usage of the drug at any time, effectively restricts the abuse of anesthetics, and curbs the illegality caused by the anesthetics. behavior.
According to the Korean medical insurance department: “By 2020, RFID technology will be widely used in the field of narcotic drug supervision and strictly supervise the manufacture and circulation of related drugs in South Korea. This will cause a landmark change in the field of medical supervision.”
[ad_2]